11/20
08:07 am
vvos
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $6.60 price target on the stock.
Medium
Report
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $6.60 price target on the stock.
11/19
12:22 pm
vvos
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its price target lowered by analysts at Alliance Global Partners from $8.25 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its price target lowered by analysts at Alliance Global Partners from $8.25 to $6.00. They now have a "buy" rating on the stock.
11/17
08:19 am
vvos
Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/14
04:17 pm
vvos
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
High
Report
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
11/14
04:05 pm
vvos
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Medium
Report
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
11/13
05:00 pm
vvos
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Low
Report
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
10/8
07:30 am
vvos
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
Medium
Report
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
9/25
08:23 am
vvos
Wesper sleep platform reduces nerve stimulation titration time by 45% [Yahoo! Finance]
Medium
Report
Wesper sleep platform reduces nerve stimulation titration time by 45% [Yahoo! Finance]
9/19
07:00 am
vvos
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
High
Report
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
9/18
10:08 am
vvos
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children [Yahoo! Finance]
Medium
Report
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children [Yahoo! Finance]
9/18
07:00 am
vvos
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
High
Report
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring